LabGenius is the first biopharmaceutical company developing next generation protein therapeutics using a machine learning-driven evolution engine (EVA™). Our protein engineering platform integrates several bleeding edge technologies from the fields of machine learning, synthetic biology and robotics.
| Website | http://www.labgeni.us |
| Revenue | $12.7 million |
| Employees | 65 (3 on RocketReach) |
| Founded | 2012 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+30 more
(view full list)
|
| Industry | Biotechnology Research, Artificial Intelligence, Data and Analytics, Science and Engineering, Software, Biotechnology, Machine Learning, Robotics, Hardware, Therapeutics, Health Care |
| Keywords | Innovative Therapeutics, Protein Engineering, Pharmaceutical Technology, Biopharmaceutical, Machine Learning, Protein Therapeutics, Drug Discovery, Therapeutics, Pharmaceutical, Biotechnology, Next Generation Therapeutics, Protein Design, Drug Development, Biotechnology Platform, Artificial Intelligence, Deep Learning, Molecular Engineering, Precision Medicine |
| Competitors | Regeneron, Illumina, Twist Bioscience, Amgen, Geno, Novozymes, Zymergen, Inc., Synthace, Arzeda, Base Genomics +40 more (view full list) |
Looking for a particular LabGenius employee's phone or email?
The LabGenius annual revenue was $12.7 million in 2026.
3 people are employed at LabGenius.